Document is current
Any future updates will be listed below
-
Authors
Tilford, J. Mick https://orcid.org/0000-0003-3759-1644
Tarlan, Aygul
- License Information
-
More Information
Article History
Accepted: 4 October 2023
First Online: 2 November 2023
Declarations
:
: J. Mick Tilford receives consulting fees from Merck. Aygul Tarlan has no conflicts of interest that are directly relevant to the content of this editorial.
: Not applicable.
: Not applicable.
: Not applicable.
Free to read: This content has been made available to all.
